Martin S Tallman Selected Research

Martin S Tallman Research Topics

Disease

129	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2024 - 03/2002
61	Neoplasms (Cancer) 01/2023 - 10/2002
59	Acute Promyelocytic Leukemia 12/2023 - 01/2002
57	Leukemia 12/2023 - 04/2002
34	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2023 - 08/2002
26	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 03/2022 - 10/2002
16	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2024 - 10/2002
12	Philadelphia Chromosome 01/2021 - 10/2002
11	Hairy Cell Leukemia 10/2023 - 04/2002
11	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2019 - 10/2002
9	Hematologic Neoplasms (Hematological Malignancy) 01/2020 - 01/2002
8	Thrombocytopenia (Thrombopenia) 03/2022 - 06/2002
7	Infections 10/2023 - 08/2002
7	Hyperbilirubinemia 01/2021 - 03/2014
7	Hemorrhage 11/2019 - 03/2005
6	Breast Neoplasms (Breast Cancer) 08/2011 - 07/2003
5	Febrile Neutropenia 03/2022 - 06/2007
5	Neutropenia 10/2021 - 02/2007
5	Anemia 01/2021 - 11/2005
5	Lymphoma (Lymphomas) 01/2020 - 10/2002
5	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 12/2019 - 12/2013
4	Hypersensitivity (Allergy) 01/2021 - 03/2014
4	Drug-Related Side Effects and Adverse Reactions 06/2009 - 11/2005
3	Fever (Fevers) 12/2022 - 09/2012
3	Pathologic Complete Response 12/2021 - 12/2006
3	Primary Myelofibrosis (Myelosclerosis) 10/2021 - 11/2010
3	Hyperglycemia 01/2021 - 01/2020
3	Residual Neoplasm 01/2021 - 06/2011
3	Fatigue 01/2020 - 05/2012
3	Headache (Headaches) 01/2020 - 01/2003
3	Multiple Myeloma 01/2016 - 10/2002
3	Disease Progression 03/2013 - 03/2007
3	Chronic Renal Insufficiency 11/2012 - 09/2004
3	Leukocytosis (Pleocytosis) 12/2009 - 04/2005
2	Pneumonia (Pneumonitis) 12/2022 - 01/2020
2	Exanthema (Rash) 12/2022 - 10/2015
2	Chromosome Aberrations (Chromosome Abnormalities) 01/2022 - 09/2012

Drug/Important Bio-Agent (IBA)

36	Tretinoin (Retinoic Acid)FDA LinkGeneric 12/2023 - 10/2002
23	Arsenic Trioxide (Trisenox)FDA Link 12/2023 - 01/2002
19	AnthracyclinesIBA 01/2023 - 08/2002
19	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2022 - 08/2002
14	Phosphotransferases (Kinase)IBA 11/2023 - 08/2003
14	Proteins (Proteins, Gene)FDA Link 11/2023 - 10/2002
10	Gemtuzumab (Mylotarg)FDA Link 01/2018 - 03/2002
9	Daunorubicin (Cerubidine)FDA LinkGeneric 01/2023 - 01/2003
8	DNA (Deoxyribonucleic Acid)IBA 11/2023 - 10/2009
8	Asparaginase (Elspar)FDA Link 01/2023 - 01/2003
8	Erythropoietin FDA Link 01/2021 - 10/2002
8	Imatinib Mesylate (Gleevec)FDA Link 02/2014 - 10/2002
7	Rituximab (Mabthera)FDA Link 10/2023 - 10/2002
7	venetoclaxIBA 01/2022 - 01/2018
7	enasidenibIBA 01/2021 - 10/2017
6	Aligeron (AS 2)IBA 03/2024 - 11/2006
6	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 10/2023 - 06/2013
6	pegaspargase (Oncaspar)FDA Link 01/2023 - 03/2014
6	Azacitidine (5 Azacytidine)FDA Link 01/2021 - 10/2009
6	Immunoconjugates (Immunoconjugate)IBA 10/2020 - 10/2002
6	Alemtuzumab (Campath)FDA Link 01/2019 - 10/2002
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2019 - 07/2003
5	Monoclonal AntibodiesIBA 03/2022 - 10/2002
5	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 10/2021 - 12/2006
5	fludarabineIBA 01/2015 - 05/2004
4	VemurafenibIBA 10/2023 - 10/2015
4	midostaurinIBA 01/2022 - 01/2017
4	InterferonsIBA 01/2021 - 04/2002
4	Erythropoietin Receptors (Erythropoietin Receptor)IBA 01/2021 - 02/2008
4	purineIBA 10/2015 - 10/2002
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2011 - 01/2004
3	Tyrosine (L-Tyrosine)FDA Link 11/2023 - 03/2011
3	ivosidenibIBA 01/2021 - 01/2020
3	Interferon-alpha (Interferon Alfa)IBA 01/2021 - 05/2005
3	fms-Like Tyrosine Kinase 3IBA 10/2020 - 01/2013
3	Histones (Histone)IBA 01/2020 - 08/2006
3	Tyrosine Kinase InhibitorsIBA 12/2019 - 02/2017
3	alpha-hydroxyglutarateIBA 12/2018 - 12/2010
3	Protein Isoforms (Isoforms)IBA 12/2018 - 11/2015
3	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 01/2018 - 08/2002
3	Biomarkers (Surrogate Marker)IBA 04/2017 - 05/2012
3	entinostat (MS 275)IBA 02/2016 - 10/2009
3	EnzymesIBA 01/2016 - 01/2010
3	Cladribine FDA LinkGeneric 06/2011 - 05/2004
3	Prednisone (Sone)FDA LinkGeneric 11/2010 - 01/2003
3	Eukaryotic Initiation Factor-4EIBA 10/2010 - 02/2005
3	ArsenicIBA 09/2010 - 07/2008
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 03/2022 - 01/2020
2	CholesterolIBA 01/2022 - 05/2007
2	ChromatinIBA 01/2022 - 10/2014

Therapy/Procedure

110	Therapeutics 12/2023 - 04/2002
69	Drug Therapy (Chemotherapy) 01/2022 - 06/2002
18	Cell Transplantation 12/2023 - 02/2008
13	Hematopoietic Stem Cell Transplantation 12/2021 - 07/2003
12	Induction Chemotherapy 11/2021 - 06/2002
12	Transplantation 01/2021 - 07/2003
8	Homologous Transplantation 01/2018 - 02/2008
6	Salvage Therapy 12/2021 - 05/2004
4	Immunotherapy 10/2020 - 01/2016
4	Consolidation Chemotherapy 11/2019 - 02/2006
4	Autologous Transplantation 05/2011 - 02/2006
3	Stem Cell Transplantation 01/2021 - 07/2003
3	Adjuvant Chemotherapy 01/2010 - 07/2003